MarketPulse
B

$BTAI

2 articles found
0 positive
1 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

$BIOXCEL Settlement: $9.75M Class Action Approved for Securities Fraud Claims

BioXcel Therapeutics settles $9.75M class action over securities purchased March-June 2023. Fairness hearing scheduled September 2026.
BTAIinvestor compensationsecurities litigation
GlobeNewswire Inc.GlobeNewswire Inc.··Bioxcel Therapeutics, Inc.

BioXcel Therapeutics Raises $8M via Direct Offering Amid Market Challenges

BioXcel Therapeutics raises $8M via direct offering of 4.5M shares at $1.739/share, with warrant modifications agreed, closing expected March 2026.
BTAIartificial intelligencewarrants